The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum is a research paper published in Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 (AG05064)
National Institutes of Health
Grant: U01 (AG024904)
National Institute on Aging
Grant: RF1 (AG064926)
NIA NIH HHS
Grant: U19 AG024904
NIA NIH HHS
Grant: U01 AG024904
NINDS NIH HHS
Grant: R35 NS097976
NIA NIH HHS
Grant: RF1 AG064926
NIA NIH HHS
Grant: R01 AG066088
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 5R35NS097976-04
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
National Institutes of Health
Grant: 1RF1AG064926-01
Fibrinogen and vascular cognitive impairment: mechanisms, imaging, therapeutics
AstraZeneca
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
BioClinica
Pfizer
Novartis Pharmaceuticals Corporation
Takeda Pharmaceutical Company
Amorfix Life Sciences
GE Healthcare
Eli Lilly and Company
Servier
FWCI
1.43
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals